IgE/FcεRI-Mediated Antigen Cross-Presentation by Dendritic Cells Enhances Anti-Tumor Immune Responses
Open Access
- 1 March 2015
- journal article
- Published by Elsevier in Cell Reports
- Vol. 10 (9) , 1487-1495
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Cross-presentation by dendritic cellsNature Reviews Immunology, 2012
- IgE and mast cells in allergic diseaseNature Medicine, 2012
- Cancer immunotherapy via dendritic cellsNature Reviews Cancer, 2012
- Induction of IgM, IgA and IgE Antibodies in Colorectal Cancer Patients Vaccinated with a Recombinant CEA ProteinJournal of Clinical Immunology, 2012
- Soluble IgE receptors—Elements of the IgE networkImmunology Letters, 2011
- Targeting HER2/neu with a fully human IgE to harness the allergic reaction against cancer cellsCancer Immunology, Immunotherapy, 2011
- Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8−CD11b+dendritic cellsProceedings of the National Academy of Sciences, 2011
- Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cellsJournal of Experimental Medicine, 2010
- IL‐4 inhibits VLA‐4 expression on Tc1 cells resulting in poor tumor infiltration and reduced therapy benefitEuropean Journal of Immunology, 2008
- Dendritic-cell immunotherapy: from ex vivo loading to in vivo targetingNature Reviews Immunology, 2007